---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-24-000419"
form_type: "8-K"
ticker: "LNAI"
cik: "0001527728"
company_name: "Lunai Bioworks Inc."
filed_at: "2024-03-13T23:59:59+00:00"
generated_at: "2026-06-04T22:13:53.801665+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Renovaro appoints Simon Tarsh as Interim CFO; outgoing CFO Puche departs

## Summary
- Simon Tarsh named Interim CFO effective March 11, 2024; replaces Ms. Puche who leaves after >5 years.
- Consulting agreement pays Tarsh PB Advisors $25,000/month plus up to 30% bonus on milestones.
- Bonuses tied to timely SEC filings and hiring a permanent CFO before agreement termination.
- Term is 6 months, renewable monthly; may be terminated by either party on 30 days' notice.
- Tarsh receives 10,000 stock options, vesting if a new CFO is hired prior to termination date.

## SEC filing metadata
- accession: 0001731122-24-000419
- form_type: 8-K
- ticker: LNAI
- cik: 0001527728
- company_name: Lunai Bioworks Inc.
- filed_at: 2024-03-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1527728/000173112224000419/0001731122-24-000419-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1527728/000173112224000419/e5493_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-24-000419
- JSON: https://secwatch.observer/filing/0001731122-24-000419.json
- Plain text: https://secwatch.observer/filing/0001731122-24-000419.txt

## Key facts
- Executive change
  Ms. Puche departed as Chief Financial Officer at Lunai Bioworks Inc..
  - Action: departed
  - Role: Chief Financial Officer
  source text: Ms. Puche, the Company’s outgoing Chief Financial Officer, said: “After more than 5 years at the Company, I am ready for a new phase in my life.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1527728/000173112224000419/0001731122-24-000419-index.htm
- Executive change
  Simon Tarsh was appointed as Interim Chief Financial Officer at Lunai Bioworks Inc..
  - Action: appointed
  - Role: Interim Chief Financial Officer
  source text: The board of directors (the “Board”) of Renovaro Inc. (the “Company”) appointed Simon Tarsh, age 63, as Interim Chief Financial Officer of the Company, effective March 11, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1527728/000173112224000419/0001731122-24-000419-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.